PDCD1 and cutaneous melanoma: In this context, a recently published first-in-human study in advanced cutaneous melanoma patients treated with personalized RNA vaccines demonstrated objective responses, and even one complete response in conjunction with PD-1 inhibition [60], showing a possible treatment approach also for uveal melanoma.